Trials / Conditions / HER2-positive Advanced Solid Tumors
HER2-positive Advanced Solid Tumors
4 registered clinical trials studyying HER2-positive Advanced Solid Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors NCT05681650 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Unknown | A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors NCT05810103 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Recruiting | SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors NCT05245058 | Shanghai Pharmaceuticals Holding Co., Ltd | EARLY_Phase 1 |
| Completed | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms NCT03219268 | MacroGenics | Phase 1 |